Picture of Fresh Tracks Therapeutics logo

FRTX — Fresh Tracks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapTurnaround

Brief: Brickell Biotech Inc - R. Michael Carruthers, CFO And Principal Accounting Officer, Will Be Resigning

Nov 24 (Reuters) - Brickell Biotech Inc  BBI.O :
    * BRICKELL BIOTECH INC - R. MICHAEL CARRUTHERS, CO'S CFO AND
PRINCIPAL ACCOUNTING OFFICER, WILL BE RESIGNING FROM THESE
POSITIONS WITH CO
    * BRICKELL BIOTECH INC - ALBERT (BERT) N. MARCHIO, II HAS
BEEN
APPOINTED BY BOARD TO SUCCEED CARRUTHERS AS CFO, EFFECTIVE DEC
1, 2020

Source text for Eikon:  ID: 
Further company coverage:  BBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fresh Tracks Therapeutics

See all news